• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1991 Fiscal Year Final Research Report Summary

Synergistic anti-tumor activity between IL-2-cultured lymphocytes and fresh lymphocytes

Research Project

Project/Area Number 02807112
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field General surgery
Research InstitutionKyoto University

Principal Investigator

KAN Norimichi  Kyoto University Faculty of Medicine Research Assister, 医学部, 助手 (50186160)

Project Period (FY) 1990 – 1991
KeywordsInterleukin-2 / Killer T cells / Adoptie immund therapy / Immuno chemo therapy / OK-432 / Cyclophosphamide / CD8+cells / Synergistic antitumor activity
Research Abstract

Fresh lymphocytes(FL)in cancer patients were cultured for 13 days with T-cell growth factor, interleukin-2 and sonicated tumor extract. We examined lysis of autologous tumor cells(12-h 5ICr release test)by cultured lymphocytes(CL)when the same number of CL and FL were added to the assay system(E/T=40 : 1).
1. A randomized protocol study in Stage II or Ill breast cancer patients shows suppressive activitv of FL in 3/9 of no treatment group, but no suppressive activity in immuno-chemotherapy(OK-432 and cyclophosphamide)group(enhanced activity in 3/7).
2. In 18 patients with liver metastases from breast cancer, FL in 6/18 showed enhanced activity and in 7/18 suppressive activity in the lysis of autologous tumor cells of CL.
3. In flow cytometric analysis, CD8+CDllb+ cells and CD16+ cells significantly decreased after immuno-chemotherapy in both groups(Stage ll, or III breast cancer and liver metastases from breast cancer)
4. In vitro assays using autologous and allogerieic tumor fells, FL showed some specificity in enhanced and suppressive activity against the cytotoxicity of CL.
5. The main population of FL which influenced the cytotoxicity of CL W. 3. s plastic rionakihererit. And especially CD8-depleted FL enhanced the cytotoxicitv of CL.
6. In liver metastases from breast cancer, the survival after recurrence w as prolonged in enhanced group but survival after treatment was not significantly prolonged in enhanced group.
These results suggest that immuno-chemotherapy eliminates suppressive population in FL and may induce the synergistic activity between FL and CL against autologous tumor cells. To clarify the mechanism of AIT, we should pay attention to cellular interaction among autologous tumor cells, transferred cultured cells and host fresh cells induced by immuno-chemotherapy.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] S.Yamasaki: "Synergistic activity between IL-2-cultured lymphocytes and fresh lymphocytes in cancer patients on the lysis of autologous tumors." J Cancer Res Clin Oncol. 116. 343 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山崎 誠二: "培養killer T移入療法の奏効機序ー特にkiller Tと宿主リンパ球の抗腫瘍協調作用について" 日本外科学会雑誌. 91. 343 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山崎 誠二: "自己腫瘍細胞に対する培養キラ-組胞と宿主リンパ球の相互作用" BIOTHERAPY. 5(6). 1188-1194 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山崎 誠二: "自己腫瘍細胞に対する培養キラ-細胞と宿主リンパ球との相互作用ー宿主リンパ球subpopulationと増強または抑制作用" 第50回日本癌学会総会記事. 202 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 山崎 誠二: "担癌患者リンパ球と移入キラ-T細胞との抗腫瘍協調作用の観点からみたimmunoーchemoーlymphocytotherapyの合理性" 日本癌治療学会誌. 26(9). 131 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Yamasaki: "Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes from patients treated with immuno-chemo-therapy" Cancer Immunol Immunother.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 管典道: "がん治療のあゆみ第10巻分担執筆:Adoptive immunotherapyの奏効機序の解明ー特に宿主リンパ球と移入killer T細胞の抗腫瘍協調作用についてー" 財典法人がん集学的治療研究財団, 164 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S. Yamasaki: "Synergistic activity between IL-2-cultured and fresh lymphocytes in cancer patients on the lysis of autologous tumors." J Cancer Res Clin Oncol. 116. 343 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Yamasaki: "Mechanism of tumor response in adoptive immunotherapy - Synergistic anti-tunmor activity between IL-2-cultured lymphocytes and fresh lymphocytes" J Jpn Surg Soc. 91. 343 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Yamasaki: "Interaction between IL-2-cultured lymphocytes and fresh lymphocytes in lysis of autologous tumors in cancer patients" Biotherapy. 5(6). 1188-1194 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Yamasaki: "Interaction between IL-2-cultured lymphocytes and fresh lymphocytes in cancer patients on the lysis of autologous tumors - Relationship between subpopulation of fresh lymphocytes and synergistic or inhibitory effects" Jpn J Cancer Res 50th annual Meeting proceedings. 202. (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Yamasaki: "Antitumor mechanism of immuno-chemo-lymphocyto-therapy by synergism between IL-2-cultured lymphocytes and fresh lymphocytes against autologous tumors in cancer patients" J Jpn Soc Cancer Ther. 27(2). 103 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S. Yamasaki: "Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes from patients treated with immuno-chemotherapy" Cancer Immunol Immunother.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] N. Kan: "Mechanism of clinical response in adoptive immunotherapy - synergistic antitumor effect between cultured killer T cells and fresh lymphocytes" Advances in Cancer Treatment : 10th ed. Japanese Foundation for Multidiscplinary Treatment of Cancer. 45-52 (1990)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi